Home NDC 57520-0413 Hepapar
Product NDC 57520-0413
11-digit product format 575200413
Labeler code 57520
Product ID 57520-0413_697162a0-93e8-4d4a-a7f6-df60e630020b
Type HUMAN OTC DRUG
Nonproprietary name Carduus marianus, Chelidonium majus, Taraxacum officinale
Dosage form LIQUID
Route ORAL
Labeler Apotheca Company
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2010-05-21
Marketing end 2022-09-05
Substance CHELIDONIUM MAJUS; CHENOPODIUM AMBROSIOIDES; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; PHOSPHORUS; PORK LIVER; SILYBUM MARIANUM SEED; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE
Active strength 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 57520-0413-1 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 57520-0413-1 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 57520-0413-1 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 57520-0413-1 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 57520-0413-1 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 57520-0413-1 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 57520-0413-1 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 57520-0413-1 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 57520-0413-1 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 57520-0413-1 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 57520-0413-1 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 57520-0413-1 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 57520-0413-1 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 57520-0413-1 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 57520-0413-1 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 57520-0413-1 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 57520-0413-1 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 57520-0413-1 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CHELIDONIUM MAJUS ACTIVE INGREDIENT 7E889U5RNN HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 CHENOPODIUM AMBROSIOIDES ACTIVE INGREDIENT 4H5RSU087I HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 LYCOPODIUM CLAVATUM SPORE ACTIVE INGREDIENT C88X29Y479 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 MERCURIUS SOLUBILIS ACTIVE INGREDIENT 324Y4038G2 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 PHOSPHORUS ACTIVE INGREDIENT 27YLU75U4W HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 PORK LIVER ACTIVE INGREDIENT 6EC706HI7F HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 SILYBUM MARIANUM SEED ACTIVE INGREDIENT U946SH95EE HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 SODIUM SULFATE ACTIVE INGREDIENT 0YPR65R21J HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 STRYCHNOS NUX-VOMICA SEED ACTIVE INGREDIENT 269XH13919 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 TARAXACUM OFFICINALE ACTIVE INGREDIENT 39981FM375 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 CHELIDONIUM MAJUS ACTIVE MOIETY 7E889U5RNN HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 CHENOPODIUM AMBROSIOIDES ACTIVE MOIETY 4H5RSU087I HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 LYCOPODIUM CLAVATUM SPORE ACTIVE MOIETY C88X29Y479 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 MERCURIUS SOLUBILIS ACTIVE MOIETY 324Y4038G2 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 PHOSPHORUS ACTIVE MOIETY 27YLU75U4W HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 PORK LIVER ACTIVE MOIETY 6EC706HI7F HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 SILYBUM MARIANUM SEED ACTIVE MOIETY U946SH95EE HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 SODIUM CATION ACTIVE MOIETY LYR4M0NH37 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 STRYCHNOS NUX-VOMICA SEED ACTIVE MOIETY 269XH13919 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 TARAXACUM OFFICINALE ACTIVE MOIETY 39981FM375 HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 ALCOHOL INACTIVE INGREDIENT 3K9958V90M HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2 WATER INACTIVE INGREDIENT 059QF0KO0R HEPAPAR (CARDUUS MARIANUS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE) LIQUID [APOTHECA COMPANY] 2
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 57520-0413-1 57520041301 30 mL in 1 BOTTLE, DROPPER (57520-0413-1) 30 ml 2010-05-21 2022-09-05 No No Current